SCOPA 2022: A review of topical medication classes in eyecare

Video

Brad Sutton, OD, FAAO, FORS, shares highlights from his SCOPA 2022 presentation, "Topical Pharmacology Rounds."

Brad Sutton, OD, FAAO, FORS, clinical professor at Indiana University School of Optometry, and service chief of the Indianapolis Eye Care Center speaks with Optometry Times® editor Kassi Jackson, sharing highlights from his presentation, "Topical pharmacology rounds," which he presented during this year's South Carolina Optometric Physicians Association's (SCOPA) annual meeting in hilton Head.

This transcript has been lightly edited for clarity:

Brad Sutton, OD, FAAO, FORS:

This is a talk I've given ... throughout the country, and it seems to be a pretty well-received review of basically all topical medication classes that we use in optometry—or eyecare.— in general.

I kind of cover each drug that we have out there, kind of hit on some newer drugs that are just coming to the market, some things in the pipeline a little bit.

And the goal is to give a little bit of background on how the drugs work, and how one drug may be similar or different from another, but my real goal during the talk is always to say, "Okay, here are some clinical nuances between drug X and drug Y," and help attendees better use those medications in their practice to take care of their patients.

We cover antibiotics, anti-inflammatories, nonsteroidal anti-inflammatories, allergy medicines, glaucoma drops, antivirals, and basically every category you can think of.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Eva Kim, MD, shares visual outcomes of EVO implantable collamer lens in patients with low to moderate myopia
Drs Brianna Rhue and Diana Canto-Sims discuss the benefits of implementing a contact lens management system that can help improve lens sales at your practice.
Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD; detailed what optometrists can expect to change when HB 1353's regulations are enacted later this year.
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
© 2025 MJH Life Sciences

All rights reserved.